Wen Cheng

Title: The Innovations of Wen Cheng

Introduction

Wen Cheng is a notable inventor based in Suzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of JAK inhibitors. With a total of 2 patents to his name, Cheng's work is paving the way for advancements in medication and treatment methods.

Latest Patents

Cheng's latest patents include a crystalline form of Di-p-toluoyl-L-tartrate of upadacitinib. This application provides a salt compound of upadacitinib and outlines a preparation method that features easy operational procedures, affordable raw materials, and effective purification processes. These attributes are beneficial for industrial production. Another significant patent involves synthesis methods for upadacitinib and its intermediates. This disclosure relates to a JAK inhibitor upadacitinib intermediate and its preparation method, showcasing Cheng's expertise in pharmaceutical innovation.

Career Highlights

Wen Cheng is currently associated with Suzhou Pengxu Pharmatech Co., Ltd., where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to improving drug formulations and enhancing therapeutic efficacy.

Collaborations

Cheng collaborates with talented individuals in his field, including Peng Wang and Pixu Li. These partnerships contribute to the innovative environment at Suzhou Pengxu Pharmatech Co., Ltd.

Conclusion

Wen Cheng's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as a key innovator. His work not only advances medical science but also demonstrates the importance of innovation in improving healthcare solutions.